USPTO serial 79313560
BIOSYNEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 12, 2023
- Examiner
- SEVERSON, JUSTIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOSYNEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JOSEPH SOFER
JOSEPH SOFER IPSILON USA, LLP110 W 40TH STREETSUITE 2001NEW YORK, NY 10018Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in industry and science; chemical reagents, other than for medical or veterinary purposes ; diagnostic preparations other than for medical or veterinary purposes ; Chemically-treated nonmedical strips for chemical and biological analysis | ACTIVE | — |
| 005 | Chemical and biological reagents and products for medical or veterinary purposes, namely, reagents for use in diagnostic tests, reagents for use in diagnostic tests for screening purposes, reagents for medical use, chemical reagents for medical purposes, diagnostic biomarker reagents for medical use; immunoassay reagents for medical use, reagent paper for medical purposes; reagents and preparations for pregnancy tests, chemical preparations for use in DNA medical analysis and Chemicals for use in RNA analysis for medical purposes; diagnostic products for medical purposes, namely, medical diagnostic test strips for the detection of coronavirus, viruses, bacteria or parasite for medical purposes, medical diagnostic test strips for measuring blood glucose levels, medical diagnostic test strips for measuring cholesterol levels, triglycerides, cardiac markers or any other biomedical marker; testing kits comprised of medical diagnostic agents, preparations and substances for medical purposes for use in disease detection, namely, coronavirus, HIV, respiratory viral infections, hepatitis B, hepatitis C, influenza, infectious mononucleosis, dengue, norovirus, rotavirus, adenovirus, urinary tract infections, colorectal cancer, C-reactive protein, cyclic citrullinated peptide, premature rupture of the fetal membranes, Chlamydia trachomatis, helicobacter pylori, legionnaire's disease, pneumonia, syphilis, tetanus, malaria, mycoses, herpes, rubella, whooping cough, Lyme disease; preparations and substances for medical purposes for use in drugs detection, namely, amphetamines, buprenorphine, cocaine, cotinine, methadone, fentanyl, methamphetamines, morphine, oxycodone, phencyclidine, cannabis, tramadol; pregnancy test kits and ovulation test kits for home use; diagnostic test kits comprised of medical diagnostic, for medical purposes for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; in vitro diagnostic preparations for medical use for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; self-testing diagnostic kits comprising in vitro diagnostic agents, preparations and substances for medical purposes for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; medical diagnostic test kits for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; medical diagnostic reagents and assays for testing of body fluids for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; medical diagnostic reagents; chemical reagents for medical or veterinary purposes | ACTIVE | — |
| 010 | Diagnostic apparatus for medical purposes, namely, blood testing apparatus; genetic testing apparatus for medical purposes; diagnostic test readers for medical use; medical diagnostic apparatus for testing DNA and RNA samples; medical apparatus and instruments, namely, instruments for loop-mediated isothermal amplification for medical purposes; quantitative Polymerase Chain Reaction [PCR] instruments for medical use; real-time polymerase chain reaction (PCR) instruments for medical purposes; testing instruments for medical diagnostic purposes, namely, for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; capillary tubes for samples; medical specimen cups; specimen cup holders; apparatus for taking body fluid samples, namely, medical devices for obtaining body fluid samples; gloves for medical purposes, sanitary masks for medical purposes, thermometers for medical use, chemically activated hot and cold gel packs for medical purposes; cooling patches for medical purposes; Ice bags for medical purposes, first-aid cooling patches, elastic bandages, Bandages for orthopaedic purposes | ACTIVE | — |
| 042 | Chemical analysis and research services; biological research; bacteriological research; chemical research; pharmaceutical research services; calibration of devices employed in such services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOSYNEX
- Other trademarks owned by BIOSYNEX
- Other trademarks owned by BIOSYNEX
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named BIOSYNEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 2, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 12, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 12, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 12, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 12, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 12, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 27, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 27, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 7, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 7, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 7, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 24, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 24, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 24, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 24, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 24, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 28, 2023 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Mar 9, 2023 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Mar 9, 2023 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Mar 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 6, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 6, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 11, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 23, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 9, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 9, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 9, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 23, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 23, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 23, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 9, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 8, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 7, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 7, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 20, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 19, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2021 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |